.@UWMadison_BME’s Sarah Gong is part of a @UWMadison team developing a new therapy for restoring vision in patients with retinal disorders caused by nonsense mutations through a $7.7 million @NatEyeInstitute grant. #UWimpact https://t.co/8vOEEgUbuD

@UWMadEngr